Ex Vivo and In Vivo Regulation of Lipocalin-2, a Novel Adipokine, by Insulin

OBJECTIVE—Lipocalin-2, a novel adipokine, has been shown to be elevated in obese, insulin-resistant, and diabetic subjects. We therefore sought to study the ex vivo and in vivo effects of insulin on lipocalin-2 levels in humans. RESEARCH DESIGN AND METHODS—We investigated the in vivo effects of insu...

Descripción completa

Detalles Bibliográficos
Autores principales: Tan, Bee K., Adya, Raghu, Shan, Xiaoye, Syed, Farhatullah, Lewandowski, Krzysztof C., O'Hare, John P., Randeva, Harpal S.
Formato: Texto
Lenguaje:English
Publicado: American Diabetes Association 2009
Materias:
Pathophysiology/Complications
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2606846/
https://www.ncbi.nlm.nih.gov/pubmed/18852336
http://dx.doi.org/10.2337/dc08-1236

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2606846/
https://www.ncbi.nlm.nih.gov/pubmed/18852336
http://dx.doi.org/10.2337/dc08-1236

Ejemplares similares